Changli Wang

机构：Northwest Institute of Nuclear Technology · ORCID：0009-0000-1071-4443

发表论文 29 篇 · 总被引 520 次 · h-index 11

代表论文

• Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patients (2022 · Translational Lung Cancer Research · 被引 124)
• LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers (2020 · Cancer Letters · 被引 98)
• Identification of a three-miRNA signature as a blood-borne diagnostic marker for early diagnosis of lung adenocarcinoma (2016 · Oncotarget · 被引 67)
• Heterointerface-Enabled Anti-Reverse-Current Electrodes for Alkaline Water Electrolyzers at 1000 mA cm –2 (2025 · Journal of the American Chemical Society · 被引 32)
• lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling (2019 · Oncology Reports · 被引 22)
• Long non‑coding RNA SNHG17 promotes lung adenocarcinoma progression by targeting the microRNA‑193a‑5p/NETO2 axis (2021 · Oncology Letters · 被引 20)